对乙酰氨基酚大量过量:活性炭与增加乙酰半胱氨酸剂量效果的观察性研究(ATOM-2)
本研究通过澳大利亚对乙酰氨基酚项目前瞻性观察新南威尔士州和昆士兰州毒物信息中心病例,并结合三个临床毒理学单位数据库回顾性分析,纳入200例即刻释放型对乙酰氨基酚过量(≥40 g,摄入≤8小时)患者。中位摄入剂量50 g,中位对乙酰氨基酚浓度比1.9,193例接受乙酰半胱氨酸治疗(中位时间6.3小时),28例(14%)发生肝毒性(ALT>1000 U/L)。摄入4小时内接受活性炭者(n=33)对乙酰氨基酚浓度比显著低于未接受者(1.4 vs 2.2,p<.0001),肝毒性未调整OR为0.12(95%CI <0.001-0.91),调整乙酰半胱氨酸时间后OR为0.20(95%CI 0.002-1.74)。79例浓度比≥2者中43例在21小时内接受增加剂量乙酰半胱氨酸(最常见为最后一袋加倍,100至200 mg/kg/16 h),其肝毒性风险显著降低(OR 0.27,95%CI 0.08-0.94)。
要点
- 大量对乙酰氨基酚过量(≥40 g)患者中,14%(28/200)发生肝毒性(ALT>1000 U/L),即使6例在摄入8小时内接受治疗仍出现肝毒性。
- 摄入4小时内给予活性炭者(n=33)对乙酰氨基酚浓度比中位1.4,显著低于未给活性炭者(n=140)的2.2(p<.0001)。
- 摄入4小时内活性炭组肝毒性未调整OR为0.12(95%CI <0.001-0.91),调整乙酰半胱氨酸时间后OR为0.20(95%CI 0.002-1.74)。
- 对乙酰氨基酚浓度比≥2的患者中,21小时内接受增加剂量乙酰半胱氨酸者肝毒性风险显著降低(OR 0.27,95%CI 0.08-0.94),调整后OR相似。
- 增加乙酰半胱氨酸剂量最常见方案为最后一袋加倍(100至200 mg/kg/16 h)。
适用人群与场景
- 即刻释放型对乙酰氨基酚过量≥40 g,且摄入时间≤8小时的患者。
- 来自澳大利亚新南威尔士州和昆士兰州毒物信息中心的前瞻性观察(分别覆盖3年和1.5年),以及三个临床毒理学单位数据库的回顾性资料(覆盖2.5至20年)。
诊断标准与关键阈值
- 对乙酰氨基酚浓度比:摄入后4-16小时首次血药浓度与标准列线图(4小时150 mg/L)在该时间点的比值。
- 肝毒性定义:ALT >1000 U/L。
处置流程与药物剂量
- 活性炭:49例(25%)接受活性炭,中位给药时间摄入后2小时(IQR 1.5-5小时);4小时内给药者与未给药者相比对乙酰氨基酚浓度比显著降低。
- 乙酰半胱氨酸:193例接受乙酰半胱氨酸,中位开始时间摄入后6.3小时(IQR 4-9.3小时)。
- 增加乙酰半胱氨酸剂量:79例对乙酰氨基酚浓度比≥2者中43例在21小时内接受增加剂量,最常见为最后一袋加倍(100至200 mg/kg/16 h)。
研究设计与关键结果
- 研究类型:前瞻性观察研究结合回顾性数据库分析;样本量200例对乙酰氨基酚过量;中位摄入剂量50 g(IQR 45-60 g),中位对乙酰氨基酚浓度比1.9(IQR 1.4-2.9,n=173)。
- 肝毒性:28例(14%)发生ALT>1000 U/L,其中6例在摄入8小时内接受治疗。
- 活性炭效果:4小时内给药组(n=33)对乙酰氨基酚浓度比中位1.4(IQR 1.1-1.6)vs 未给药组(n=140)2.2(IQR 1.5-3.0),p<.0001;肝毒性未调整OR 0.12(95%CI <0.001-0.91),调整乙酰半胱氨酸时间后OR 0.20(95%CI 0.002-1.74)。
- 增加乙酰半胱氨酸剂量效果:肝毒性OR 0.27(95%CI 0.08-0.94),调整乙酰半胱氨酸时间和对乙酰氨基酚浓度比后OR相似。
证据类型、等级与局限
- 证据类型:前瞻性观察研究结合回顾性数据库分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于即刻释放型对乙酰氨基酚过量≥40 g且摄入≤8小时的患者,作者观察到摄入4小时内给予活性炭与对乙酰氨基酚浓度比显著降低相关(1.4 vs 2.2),肝毒性未调整OR 0.12但调整后置信区间宽且跨1。
- 对于对乙酰氨基酚浓度比≥2的患者,作者观察到21小时内增加乙酰半胱氨酸剂量(最后一袋加倍100至200 mg/kg/16 h)与肝毒性风险显著降低相关(OR 0.27,95%CI 0.08-0.94)。
- 原文结论指出,大量对乙酰氨基酚过量即使早期治疗仍可发生肝毒性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CONTEXT: Paracetamol is commonly taken in overdose, with increasing concerns that those taking "massive" overdoses have higher rates of hepatotoxicity and may require higher doses of acetylcysteine. The objective was to describe the clinical characteristics and outcomes of "massive" (≥ 40 g) paracetamol overdoses.
METHODS: Patients were identified through the Australian Paracetamol Project, a prospective observational study through Poisons Information Centres in NSW and Queensland, over 3 and 1.5 years, respectively, and retrospectively from three clinical toxicology unit databases (over 2.5 to 20 years). Included were immediate-release paracetamol overdoses ≥ 40 g ingested over ≤ 8 h. Outcomes measured included paracetamol ratio[defined as the ratio of the first paracetamol concentration taken 4-16 h post-ingestion to the standard (150 mg/L at 4 h) nomogram line at that time] and hepatotoxicity (ALT >1000 U/L).
RESULTS: Two hundred paracetamol overdoses were analysed, reported median dose ingested was 50 g (interquartile range (IQR): 45-60 g) and median paracetamol ratio 1.9 (IQR: 1.4-2.9, n = 173). One hundred and ninety-three received acetylcysteine at median time of 6.3 h (IQR: 4-9.3 h) post-ingestion. Twenty-eight (14%) developed hepatotoxicity, including six treated within 8 h of ingestion. Activated charcoal was administered to 49(25%), at median of 2 h post-ingestion (IQR:1.5-5 h). Those receiving activated charcoal (within 4 h of ingestion), had significantly lower paracetamol ratio versus those who did not: 1.4 (n = 33, IQR: 1.1-1.6) versus 2.2 (n = 140, IQR: 1.5-3.0) (p < .0001) (paracetamol concentration measured ≥ 1 h after charcoal). Furthermore, they had lower rates of hepatotoxicity [unadjusted OR: 0.12 (95% CI: <0.001-0.91); adjusted for time to acetylcysteine OR: 0.20 (95%CI: 0.002-1.74)]. Seventy-nine had a paracetamol ratio ≥2, 43 received an increased dose of acetylcysteine in the first 21 h; most commonly a double dose in the last bag (100 to 200 mg/kg/16 h). Those receiving increased acetylcysteine had a significant decrease risk of hepatotoxicity [OR:0.27 (95% CI: 0.08-0.94)]. The OR remained similar after adjustment for time to acetylcysteine and paracetamol ratio.
CONCLUSION: Massive paracetamol overdose can result in hepatotoxicity despite early treatment. Paracetamol concentrations were markedly reduced in those receiving activated charcoal within 4 h. In those with high paracetamol concentrations, treatment with increased acetylcysteine dose within 21 h was associated with a significant reduction in hepatotoxicity.
参考来源
- Chiew AL, Isbister GK, Kirby KA, et al. Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2). Clin Toxicol (Phila). 2017. PMID: 28644687. doi:10.1080/15563650.2017.1334915
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。